Cure

Jasper Therapeutics Announces Oral Presentation of Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant at ASH 2023

Retrieved on: 
Giovedì, Novembre 2, 2023
CSU, Acute myeloid leukemia, Jasper, Japan America Society of Greater Philadelphia, Cure, MDS, CD117, Syndrome, Myelodysplastic syndrome, ASH, Risk, Radiation, HCT, Exposition, Therapy, Toxicity, Monoclonal antibody, AML, Toxic epidermal necrolysis, Vaccine

The study being presented demonstrated that a regimen of briquilimab plus Flu/TBI leads to successful engraftment of donor blood stem cell without the associated short and long-term toxicities that accompany busulfan-based regimens commonly used in transplant of donor or gene-corrected cells.

Key Points: 
  • The study being presented demonstrated that a regimen of briquilimab plus Flu/TBI leads to successful engraftment of donor blood stem cell without the associated short and long-term toxicities that accompany busulfan-based regimens commonly used in transplant of donor or gene-corrected cells.
  • Based on its mechanism of action, briquilimab is known to potently synergize with radiation, leading to stem cell depletion without increasing off-target toxicity.
  • “We are pleased to be able to present positive final results from this study in an oral presentation at the ASH Annual Meeting, which support a favorable safety profile for briquilimab as well as its clinical potential in a variety of indications and patient types,” said Edwin Tucker, M.D., Chief Medical Officer of Jasper.
  • “While we have more recently prioritized our development efforts in addressing mast cell diseases, we continue to enroll a Phase 1 trial evaluating briquilimab as a second-line therapy in subjects with LR-MDS and look forward to presenting data from that study next year.”
    Details of the presentation are as follows:
    Abstract Title: Final Results from Phase 1 Study of Briquilimab, an Anti-CD117 Monoclonal Antibody, in Combination with Low Dose Irradiation and Fludarabine Conditioning, Shows Durable Remissions in Older Adults with Acute Myeloid Leukemia in Complete Remission and Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation

Yamaha Celebrates Outstanding 2023 Off-Road Racing Season with Multiple Championships

Retrieved on: 
Mercoledì, Novembre 1, 2023
Shift, Grand National Cross Country, Cru, Social media, Ford, 2010 AMA Pro American Superbike Championship, WXC, UTV, Name Your Adventure, GNCC, Motos, Quadcross of Nations, ATV, AMA, Pro stock, Blu, Breast cancer, Proven, Montgomery County, Circuit Gilles Villeneuve, United States national team, Catmose College, Plaque, Research, Jos Wienen, School, Series, Hammer, Susan G. Komen for the Cure, Cure, SBC, YXZ, SxS, DASA, Student, XC2, Collection, Phoenix, Tissue paper, Television, Yamaha

MARIETTA, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Yamaha Motor Corp., USA , proudly marks the culmination of a remarkable 2023 off-road racing season, characterized by an outstanding collection of championship victories and significant philanthropic endeavors.

Key Points: 
  • MARIETTA, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Yamaha Motor Corp., USA , proudly marks the culmination of a remarkable 2023 off-road racing season, characterized by an outstanding collection of championship victories and significant philanthropic endeavors.
  • Anderson's remarkable feat was celebrated with a $5,000 bLU cRU bonus for being the top-placing Yamaha Side-by-Side (SxS) at KOH.
  • Another Yamaha podium sweep took place at the Yamaha Racing Ironman finale of the Grand National Cross Country (GNCC) series in Crawfordsville, Indiana.
  • Additional charity endeavors at the Yamaha Racing Ironman GNCC included Yamaha bLU cRU racers, comprised of the Walker Fowler Racing and AmPro Yamaha teams, building balance bikes the Friday before race day.

The Health Equity Forum Brings Together Public and Private Sector Leaders at the United Nations during the UN General Assembly

Retrieved on: 
Venerdì, Ottobre 27, 2023
Pharmacy, Forum, Good Health, EVP, Policy, Cure, Education, Health, Health equity, Government, Kaiser Permanente, UNGA, United Nations, Medicine, MD, CVS Pharmacy, American Heart Association, Merck, United Nations General Assembly, Research, Committee, Novartis, Celebrity, Poverty, Social, Collaboration, Movement, Reduction, Sustainable development, Social determinants of health, Tourism

NEW YORK, Oct. 26, 2023 /PRNewswire/ -- A curated group of passionate leaders from both the public and private sectors came together for a special convening to launch the Health Equity Forum at the SDG Media Zone during the United Nations General Assembly (UNGA) High-Level week on September 21, 2023.

Key Points: 
  • NEW YORK, Oct. 26, 2023 /PRNewswire/ -- A curated group of passionate leaders from both the public and private sectors came together for a special convening to launch the Health Equity Forum at the SDG Media Zone during the United Nations General Assembly (UNGA) High-Level week on September 21, 2023.
  • "We need to start the conversation and not only convene leaders from the healthcare space, but also government, civil society, and other multi-stakeholders.
  • This isn't just a gathering; it's a movement," added Enrique Arbelaez, Health Equity Forum Steering Committee member and co-founder of Culture+ Group.
  • For media inquiries and additional information on the 2024 Health Equity Forum agenda, please contact:

James Beard Chefs, Global Sommeliers, and Art Community Join for Breast Cancer Awareness

Retrieved on: 
Mercoledì, Ottobre 25, 2023
Paragon, Cure, System, Heart, ILC, Family, Hereditary lobular breast cancer, Impact, Research, Friends, Recurrence, Breast cancer, University, University of Michigan, Communication, Santi Sergio e Bacco, Birth control

DETROIT, Oct. 25, 2023 /PRNewswire/ -- The Dynami Foundation has curated a list of trailblazing culture makers to join together for Breast Cancer Awareness in Detroit. In its 8th year, the foundation's Uncork for a Cure event is bringing together the healing power of art and food to curate pieces of work and provide sustenance for a cause. The fundraising event has raised over two million dollars over the years and impacted groundbreaking new research in support of lobular breast cancer through their partnership with University of Michigan's Rogel Cancer Center, University of PIttsburgh Medical Center, University of Colorado, and Karmanos Cancer Institute.

Key Points: 
  • Artwork curated by Mary Wysocki of Paragon Art Collective will be unveiled at the event from local and international artists.
  • Mike Han–whose mother and grandmother are breast cancer survivors–will be back for another year auctioning off a piece of his work in honor of breast cancer awareness.
  • Local artists Eric "El Cappy" Lowry, Amelia Currier, Takeisha Jefferson, and others will join Mike Han to support the research and awareness for lobular breast cancer.
  • They are standing with me as partners to raise awareness, and bring our community together, to fight for a cure," says Dynami founder and breast cancer survivor, Flora Migyanka.

NAIFA Sells Out Its Inaugural Apex East Regional Conference

Retrieved on: 
Martedì, Ottobre 24, 2023
National Association, Apex, Kansas City Life Insurance Company, Cure, Adviser, Chfc, CLU, CASL, Suffolk University Law School, LACP, Connection, TED (conference), Growth, Pacific Life, Allianz, Accounting, Marketing, Capital

ARLINGTON, Va., Oct. 24, 2023 /PRNewswire-PRWeb/ -- The National Association of Insurance and Financial Advisors (NAIFA) is hosting its inaugural regional conference based on its national conference named Apex. Apex East will be held today, October 24, at NAIFA's association headquarters building in Arlington, VA. Apex East is a regional spin-off of the Apex conference that was launched in August 2022 and will be held again in Arizona in September 2024.

Key Points: 
  • Apex East, NAIFA's signature professional development event, is being delivered in a regional format for 2023 and has attracted top producers and professionals from associated fields.
  • ARLINGTON, Va., Oct. 24, 2023 /PRNewswire-PRWeb/ -- The National Association of Insurance and Financial Advisors (NAIFA) is hosting its inaugural regional conference based on its national conference named Apex.
  • Apex East will be held today, October 24, at NAIFA's association headquarters building in Arlington, VA. Apex East is a regional spin-off of the Apex conference that was launched in August 2022 and will be held again in Arizona in September 2024.
  • We are particularly pleased this year to host Apex East in the world-class conference facilities at NAIFA's new headquarters building.

Elemental Excelerator to Fund 15 Climate Companies in 12th Cohort

Retrieved on: 
Martedì, Ottobre 17, 2023
Carbon, Foot, Food, Investment, Health, Climate, Geography, Magnesium, Recycling, City, Climate change, Nutrient, Urbanization, Plant, Agriculture, Gradient, Cure, Vegetable, GHG, CO2, Glacier, Heat, Fats, Elemental, Transport, Future, ACS, Biotechnology, EVS, EV, EAST, Palm oil, Deep Decarbonization Pathways Project, Soil, Workforce, Glossary of HVAC terms, Sodium, Oil, Lithium, Policy, Biorefinery, Natural Resources, Nickel, Atmosphere, Renewable energy, Hunting

HONOLULU and EAST PALO ALTO, Calif. , Oct. 17, 2023 /PRNewswire/ -- Elemental Excelerator, a leading nonprofit investor in climate technology for deep community impact, introduced its latest cohort, bringing its total amount of investments to $79M. With this latest cohort, Elemental is infusing another $12.5M into climate solutions and will spearhead the development of 15 transformative technologies crucial for heating and cooling our homes, reimagining critical resource extraction, advancing carbon removal and transforming our food system. These 15 climate companies will join an existing portfolio of more than 150 investments.

Key Points: 
  • These 15 climate companies will join an existing portfolio of more than 150 investments.
  • Elemental is expanding its support for visionary entrepreneurs who are addressing climate challenges in innovative ways.
  • Of the $12.5M invested in Cohort 12, $7.2M is allocated to companies with traditionally excluded CEOs either by gender or race/ethnicity.
  • Elemental's 12th cohort focuses on a range of societal challenges, including sustainable urbanization, building decarbonization, electric vehicle charging, last-mile logistics, recycling optimization and regenerative food production.

OncLive® and the Ruesch Center for the Cure of Gastrointestinal Cancers Name Winners of the 2023 Luminary Awards in GI Cancers

Retrieved on: 
Mercoledì, Ottobre 11, 2023
GI, Cure, Cancer, Research, Gastrointestinal cancer, EST, Company 3 TFCA Luminary Award, Creativity, The Westin Georgetown, Washington, D.C., Patient, Nursing

CRANBURY, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) -- OncLive, the nation’s leading multimedia resource for oncology professionals, and The Ruesch Center for the Cure of Gastrointestinal (GI) Cancers, part of Georgetown University’s Lombardi Comprehensive Cancer Center, announced the five winners of the 2023 Luminary Awards in GI Cancers.

Key Points: 
  • CRANBURY, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) -- OncLive, the nation’s leading multimedia resource for oncology professionals, and The Ruesch Center for the Cure of Gastrointestinal (GI) Cancers, part of Georgetown University’s Lombardi Comprehensive Cancer Center, announced the five winners of the 2023 Luminary Awards in GI Cancers.
  • The Luminary Awards in GI Cancers celebrate highly accomplished individuals for their lifetime achievements in finding cures and improving the lives of those affected by this group of cancers.
  • “The winners of the 2023 Luminary Awards are very deserving, and we are grateful for their dedication to the field.”
    The 2023 Luminary Awards winners are:
    Held in conjunction with the 14th Annual Ruesch Center Symposium, The Luminary Awards in GI Cancers reception will be held in person at the Westin Georgetown from 6:00 – 8:30 p.m. EST on Nov. 16.
  • To learn more about the Luminary Awards in GI Cancers and to register to attend, visit the event website .

Pathway to Cures Announces Venture Investment in Five Liters

Retrieved on: 
Lunedì, Ottobre 16, 2023
Research, General Health, Pharmaceutical, Philanthropy, Fund Raising, Foundation, Clinical Trials, Science, Biotechnology, Other Philanthropy, Other Science, Health, VNS, MBA, Doctor of Philosophy, Litre, Indian Council of Medical Research, Bleeding, Anemia, Sickle cell disease, MD, Northwell Health, Injury, Von Willebrand disease, VWD, Electricity, Vagus nerve stimulation, Medical research, Desmopressin, Feinstein Institutes for Medical Research, Coagulopathy, Haemophilia, Scientific Advisory Group, Tan, Hemostasis, Nature Communications, Cyclic permutation, Blood, Vagus nerve, Patient, Pharmaceutical industry, Medical device, The New York Times, Cure, Pathway

Pathway to Cures (P2C) announced today its investment of $500,000 in Five Liters, a subsidiary of Spark Biomedical, to develop therapies for treating inheritable blood and bleeding disorders.

Key Points: 
  • Pathway to Cures (P2C) announced today its investment of $500,000 in Five Liters, a subsidiary of Spark Biomedical, to develop therapies for treating inheritable blood and bleeding disorders.
  • Pathway to Cures, an affiliate of the National Bleeding Disorders Foundation, is a venture philanthropy fund focused on early-stage companies developing cures, therapies, or enabling technologies in support of the inheritable blood and bleeding disorders community.
  • This significant milestone is made possible through Five Liters' collaboration with Northwell Health’s Feinstein Institutes for Medical Research in New York.
  • Dr. Recht is Chief Medical and Scientific Officer at both Pathway to Cures and the National Bleeding Disorders Foundation (NBDF) and chairs the Pathway to Cures Scientific Advisory Group.

Pull Together for the Cure with Row House Studios Across the Nation

Retrieved on: 
Venerdì, Ottobre 13, 2023
Other Sports, Women, Sports, Fitness & Nutrition, Philanthropy, Fund Raising, Consumer, Health, Outdoors, Oncology, Cure, Cancer, Female, American Cancer Society, Research, Breast cancer, Caregiver, Music, Safety, Disease, Hill of Row, Longevity, Survivor, Woman, Nature, Patient, Birth control, Dairy

To help raise awareness for this disease and funds for research, advocacy and patient support, Row House studios across the country are pulling together to support the American Cancer Society next week.

Key Points: 
  • To help raise awareness for this disease and funds for research, advocacy and patient support, Row House studios across the country are pulling together to support the American Cancer Society next week.
  • Starting on October 14, Row House is hosting Pink Week, which will includes donation-based Pull Together for The Cure classes across the country, most of which are occurring on Saturday, October 21.
  • “At Row House, community and camaraderie are cornerstones of our brand, so we believe it’s important to pull together for a cause which impacts so many of our members, coaches and staff,” said Nik Kish, President of Row House.
  • For more information about Row House and its Pull Together for The Cure classes, visit www.therowhouse.com .

Juvenile Diabetes Cure Alliance Announces 4th Annual T1D Cure 100 Mile Challenge

Retrieved on: 
Lunedì, Ottobre 9, 2023
Research, Men, Sports, General Health, Consumer, Parenting, Children, Science, Women, Health, Running, Diabetes, JDCA, Cure, Walking, Juvenile Diabetes Cure Alliance, T1D, Publication, Quality of life, Pharmaceutical industry

The Juvenile Diabetes Cure Alliance (JDCA), the leading nonprofit organization dedicated to research and advocacy toward finding a cure for type 1 diabetes, today proudly announced the 4th annual T1D Cure 100 Mile Challenge.

Key Points: 
  • The Juvenile Diabetes Cure Alliance (JDCA), the leading nonprofit organization dedicated to research and advocacy toward finding a cure for type 1 diabetes, today proudly announced the 4th annual T1D Cure 100 Mile Challenge.
  • This year’s event is scheduled to commence on November 1st, coinciding with the start of National Diabetes Month, and will run through December 8th.
  • “We’re very excited to launch this year’s Diabetes Month awareness and fundraising event for a T1D Cure, and we are confident that it will be the best yet,” says Phil Shaw, Executive Director of the Juvenile Diabetes Cure Alliance.
  • For more information on the Juvenile Diabetes Cure Alliance’s T1D 100 Mile Challenge, please visit www.thejdca.org , or follow along on Facebook and Twitter .